Literature DB >> 32766847

The molecular functions of RIT1 and its contribution to human disease.

Richard Van1, Antonio Cuevas-Navarro1, Pau Castel1, Frank McCormick1.   

Abstract

RIT1 is a member of the Ras family of GTPases that direct broad cellular physiological responses through tightly controlled signaling networks. The canonical Ras GTPases are well-defined regulators of the RAF/MEK/ERK pathway and mutations in these are pathogenic in cancer and a class of developmental disorders termed RASopathies. Emerging clinical evidences have now demonstrated a role for RIT1 in RASopathies, namely Noonan syndrome, and various cancers including lung adenocarcinoma and myeloid malignancies. While RIT1 has been mostly described in the context of neuronal differentiation and survival, the mechanisms underlying aberrant RIT1-mediated signaling remain elusive. Here, we will review efforts undertaken to characterize the biochemical and functional properties of the RIT1 GTPase at the molecular, cellular, and organismal level, as well as provide a phenotypic overview of different human conditions caused by RIT1 mutations. Deeper understanding of RIT1 biological function and insight to its pathogenic mechanisms are imperative to developing effective therapeutic interventions for patients with RIT1-mutant Noonan syndrome and cancer.
© 2020 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  GTPases; cancer; point mutations; stress response

Year:  2020        PMID: 32766847      PMCID: PMC7787054          DOI: 10.1042/BCJ20200442

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  86 in total

1.  Biochemical characterization of the Ras-related GTPases Rit and Rin.

Authors:  H Shao; K Kadono-Okuda; B S Finlin; D A Andres
Journal:  Arch Biochem Biophys       Date:  1999-11-15       Impact factor: 4.013

2.  Rit promotes MEK-independent neurite branching in human neuroblastoma cells.

Authors:  DiAnna L Hynds; Mike L Spencer; Douglas A Andres; Diane M Snow
Journal:  J Cell Sci       Date:  2003-03-26       Impact factor: 5.285

Review 3.  The GTPase superfamily: conserved structure and molecular mechanism.

Authors:  H R Bourne; D A Sanders; F McCormick
Journal:  Nature       Date:  1991-01-10       Impact factor: 49.962

4.  Survival implications: hypertrophic cardiomyopathy in Noonan syndrome.

Authors:  Edward J Hickey; Rohit Mehta; Maryam Elmi; Kentaro Asoh; Brian W McCrindle; William G Williams; Cedric Manlhiot; Lee Benson
Journal:  Congenit Heart Dis       Date:  2011 Jan-Feb       Impact factor: 2.007

5.  Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.

Authors:  E V Rusyn; E R Reynolds; H Shao; T M Grana; T O Chan; D A Andres; A D Cox
Journal:  Oncogene       Date:  2000-09-28       Impact factor: 9.867

6.  Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation.

Authors:  Tomoko Kobayashi; Yoko Aoki; Tetsuya Niihori; Hélène Cavé; Alain Verloes; Nobuhiko Okamoto; Hiroshi Kawame; Ikuma Fujiwara; Fumio Takada; Takako Ohata; Satoru Sakazume; Tatsuya Ando; Noriko Nakagawa; Pablo Lapunzina; Antonio G Meneses; Gabriele Gillessen-Kaesbach; Dagmar Wieczorek; Kenji Kurosawa; Seiji Mizuno; Hirofumi Ohashi; Albert David; Nicole Philip; Afag Guliyeva; Yoko Narumi; Shigeo Kure; Shigeru Tsuchiya; Yoichi Matsubara
Journal:  Hum Mutat       Date:  2010-03       Impact factor: 4.878

7.  Isoproterenol-induced myocardial injury and diastolic dysfunction in mice: structural and functional correlates.

Authors:  Wesley W Brooks; Chester H Conrad
Journal:  Comp Med       Date:  2009-08       Impact factor: 0.982

8.  The spectrum of genetic variants and phenotypic features of Southeast Asian patients with Noonan syndrome.

Authors:  Ai-Ling Koh; Ee-Shien Tan; Maggie S Brett; Angeline H M Lai; Saumya Shekhar Jamuar; Ivy Ng; Ene-Choo Tan
Journal:  Mol Genet Genomic Med       Date:  2019-02-19       Impact factor: 2.183

9.  Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort.

Authors:  Hao Chen; Xin Li; Xiaoliang Liu; Jian Wang; Zhen Zhang; Jinjin Wu; Meirong Huang; Ying Guo; Fen Li; Xiumin Wang; Lijun Fu
Journal:  Orphanet J Rare Dis       Date:  2019-02-07       Impact factor: 4.123

10.  The lymphatic phenotype in Noonan and Cardiofaciocutaneous syndrome.

Authors:  Sarah Joyce; Kristiana Gordon; Glen Brice; Pia Ostergaard; Rani Nagaraja; John Short; Sandra Moore; Peter Mortimer; Sahar Mansour
Journal:  Eur J Hum Genet       Date:  2015-08-05       Impact factor: 4.246

View more
  4 in total

Review 1.  Defective protein degradation in genetic disorders.

Authors:  Pau Castel
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2022-02-11       Impact factor: 5.187

Review 2.  Neurodevelopmental disorders, immunity, and cancer are connected.

Authors:  Ruth Nussinov; Chung-Jung Tsai; Hyunbum Jang
Journal:  iScience       Date:  2022-05-30

3.  How can same-gene mutations promote both cancer and developmental disorders?

Authors:  Ruth Nussinov; Chung-Jung Tsai; Hyunbum Jang
Journal:  Sci Adv       Date:  2022-01-14       Impact factor: 14.136

4.  The RAS GTPase RIT1 compromises mitotic fidelity through spindle assembly checkpoint suppression.

Authors:  Antonio Cuevas-Navarro; Richard Van; Alice Cheng; Anatoly Urisman; Pau Castel; Frank McCormick
Journal:  Curr Biol       Date:  2021-07-07       Impact factor: 10.900

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.